Misselijkheid en Braken

Literatuur

  1. Hauer J. Feeding Intolerance in Children with Severe Impairment of the Central Nervous System: Strategies for Treatment and Prevention. Children (Basel). 2017;5(1).
  2. Jacknow DS, Tschann JM, Link MP, Boyce WT. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. Journal of Developmental and Behavioral Pediatrics. 1994.
  3. Dupuis LL, Robinson PD, Boodhan S, Holdsworth M, Portwine C, Gibson P, et al. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatr Blood Cancer. 2014;61(8):1506-12.
  4. Integraal Kankercentrum Nederland. Misselijkheid en braken (4.0). 2014. Available from: /www.pallialine.nl/misselijkheid-en-braken.
  5. Anderson A-K, Burke K, Bendle L, Koh M, McCulloch R, Breen M. Artificial nutrition and hydration for children and young people towards end of life: consensus guidelines across four specialist paediatric palliative care centres. BMJ Supportive & Palliative Care. 2019:bmjspcare-2019-001909.
  6. Brock P, Brichard B, Rechnitzer C, Langeveld N, Lanning M, Söderhäll S, et al. An increased loading dose of ondansetron: a north European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2. European Journal of Cancer. 1996;32(10):1744-8.
  7. Köseoglu V, Kürekçi A, Sorici Ü, Atay A, Özcan O. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. European journal of pediatrics. 1998;157(10):806-10.
  8. Orchard PJ, Rogosheske J, Burns L, Rydholm N, Larson H, DeFor TE, et al. A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation. Biol Blood Marrow Transplant. 1999;5(6):386-93.
  9. Parker RI, Prakash D, Mahan RA, Giugliano DM, Atlas MP. Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. Journal of pediatric hematology/oncology. 2001;23(9):578-81.
  10. Aksoylar S, Akman SA, Ozgenc F, Kansoy S. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol. 2001;18(6):397-406.
  11. Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V, et al. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatr Blood Cancer. 2009;52(2):242-7.
  12. Riad W, Altaf R, Abdulla A, Oudan H. Effect of midazolam, dexamethasone and their combination on the prevention of nausea and vomiting following strabismus repair in children. Eur J Anaesthesiol. 2007;24(8):697-701.
  13. Flank J, Robinson PD, Holdsworth M, Phillips R, Portwine C, Gibson P, et al. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer. Pediatr Blood Cancer. 2016;63(7):1144-51.
  14. Moorthy GS, Letizia M. The Management of Nausea at the End of Life. J Hosp Palliat Nurs. 2018;20(5):442-9.
  15. Nederlands Kenniscentrum Farmacotherapie bij Kinderen. Kinderformularium.  
  16. Association of Paediatric Palliative Medicine. The association of Paediatric Palliative Medicine Master formulary. 2020. 
  17. Benze G, Geyer A, Alt-Epping B, Nauck F. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepinen and cannabinoids in palliative care patients : a systematic review]. Schmerz. 2012;26(5):481-99.
  18. Koninklijke Nederlandse ter bevordering der Pharmacie. Informatiorium Medicamentorum [Internet] [cited 2021 July 27th].
Vernieuwde weergave Pallialine
Zoals u ziet heeft Pallialine een nieuw uiterlijk gekregen. Aan de inhoud van de richtlijnen is niets gewijzigd.